English
French
Press Release
|
08 |
Dec 2020 |
IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures... |
|
23 |
Nov 2020 |
IntelGenx Grants Stock Options... |
|
12 |
Nov 2020 |
IntelGenx Reports Third Quarter 2020 Financial Results... |
|
11 |
Nov 2020 |
IntelGenx Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films... |
|
09 |
Nov 2020 |
IntelGenx Announces Publication of a Study Evaluating Montelukast’s Effect on Neurological Aging... |
|
05 |
Nov 2020 |
IntelGenx to Report Third Quarter 2020 Financial Results on November 12, 2020 – Conference Call to Follow... |
|
29 |
Oct 2020 |
IntelGenx Signs Letter of Intent with Heritage Cannabis for Long-Term Cannabis Filmstrip Supply Agreement... |
|
23 |
Oct 2020 |
IntelGenx Announces Second Tranche Closing of Private Placement... |
|
21 |
Oct 2020 |
IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery T... |
|
15 |
Oct 2020 |
IntelGenx Closes U.S.$1.2 Million Private Placement Financing... |
|
27 |
Aug 2020 |
IntelGenx and Exeltis Healthcare S.L. Expand RIZAPORT® Commercialization Agreement to Include the European Union... |
|
24 |
Aug 2020 |
IntelGenx Amends Stock Options... |
|
20 |
Aug 2020 |
IntelGenx Enters into Feasibility Agreement with ATAI Life Sciences to Develop Pharmaceutical-Grade Polymeric Film-Based... |
|
13 |
Aug 2020 |
IntelGenx Reports Second Quarter 2020 Financial Results... |
|
06 |
Aug 2020 |
IntelGenx to Report Second Quarter 2020 Financial Results on August 13, 2020 – Conference Call to Follow... |
|
20 |
Jul 2020 |
IntelGenx and Tilray® Agree to Amend Certain Exclusivity Terms of Worldwide Cannabis-Infused VersaFilm® Agreement... |
|
15 |
Jul 2020 |
IntelGenx Reports Amendment of Stock Option Plan... |
|
07 |
Jul 2020 |
IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film... |
|
25 |
Jun 2020 |
IntelGenx Announces Approval of Proposed Amendments to Convertible Debentures... |
|
11 |
Jun 2020 |
IntelGenx Provides Update on RIZAPORT® VersaFilm® NDA Resubmission Process Following Type A Meeting with the FDA... |
|
10 |
Jun 2020 |
IntelGenx Poised to Launch Hand Sanitizer Business Following Receipt of Health Canada Authorization for Commercial Sale... |
|
08 |
Jun 2020 |
IntelGenx Receives Health Canada Cannabis Micro-Processing License... |
|
28 |
May 2020 |
IntelGenx Announces Intention to Issue Shares in Payment of Principal on Outstanding Debentures, and Meeting of Debentur... |
|
27 |
May 2020 |
IntelGenx Confirms Type A Meeting with the FDA Regarding RIZAPORT® VersaFilm®... |
|
14 |
May 2020 |
IntelGenx Reports First Quarter 2020 Financial Results... |
|
12 |
May 2020 |
IntelGenx Announces Intention to Amend Convertible Debentures... |
|
08 |
May 2020 |
IntelGenx to Report First Quarter 2020 Financial Results on May 14, 2020 – Conference Call to Follow... |
|
28 |
Apr 2020 |
IntelGenx Provides Status Update on Cannabis Micro-Processing License Application... |
|
23 |
Apr 2020 |
IntelGenx Changes 2020 Annual Meeting of Stockholders to a Virtual-Only Format... |
|
06 |
Apr 2020 |
IntelGenx Announces Adjusted VersaFilm® Business Strategy, Next Steps for RIZAPORT® VersaFilm® Program... |
|
27 |
Mar 2020 |
IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA... |
|
26 |
Mar 2020 |
IntelGenx Reports Fourth Quarter and Full-Year 2019 Financial Results... |
|
23 |
Mar 2020 |
INTELGENX TO REPORT FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS ON MARCH 26; CONFERENCE CALL TO FOLLOW ON MARCH ... |
|
11 |
Feb 2020 |
IntelGenx Completes C$8.2 Million Equity Offering... |
|
27 |
Jan 2020 |
IntelGenx Announces Pricing of Equity Offering... |
|
15 |
Jan 2020 |
IntelGenx Receives Health Canada Authorization to Proceed with New Amendment for Montelukast VersaFilm® Phase 2a Trial... |
|
13 |
Jan 2020 |
IntelGenx Provides Commercial Update on its Two Lead VersaFilm® Product Candidates, Cannabis-Infused Oral Film and RIZA... |
|
09 |
Jan 2020 |
IntelGenx Enters Animal Health Market by Signing Feasibility Agreement for VetaFilm™ Platform... |
|
19 |
Dec 2019 |
IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of Units... |